PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+14.61%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$378M
AUM Growth
+$378M
(+9%)
Cap. Flow
+$11M
Cap. Flow
% of AUM
2.9%
Top 10 Holdings %
Top 10 Hldgs %
31.74%
Holding
97
New
18
Increased
35
Reduced
31
Closed
12
Top Buys
| 1 |
Masimo
MASI
|
$8.26M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$5.72M |
| 3 |
Immunic
IMUX
|
$4.83M |
| 4 |
SDC
SmileDirectClub, Inc. Class A Common Stock
SDC
|
$4.21M |
| 5 |
Zymeworks
ZYME
|
$3.96M |
Top Sells
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$6.79M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$6.37M |
| 3 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$4.54M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
$3.77M |
| 5 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$3.32M |
Sector Composition
| 1 | Healthcare | 92.08% |
| 2 | Technology | 1.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Arrowhead Research
ARWR
$3.84B
| $2.58M | 0.68% |
+60,000
| New | +$2.58M |
|
52
Axsome Therapeutics
AXSM
$6.09B
| $2.49M | 0.66% |
35,010
-4,990
| -12% | -$355K |
|
53
Schrodinger
SDGR
$1.42B
| $2.38M | 0.63% |
50,000
+35,000
| +233% | +$1.66M |
|
54
KALA BIO
KALA
$105M
| $2.33M | 0.62% |
310,053
+35,053
| +13% | +$263K |
|
55
Stereotaxis
STXS
$246M
| $2.31M | 0.61% |
643,813
-24,880
| -4% | -$89.1K |
|
|
56
Madrigal Pharmaceuticals
MDGL
$9.7B
| $2.16M | 0.57% |
18,211
-31,789
| -64% | -$3.77M |
|
57
Sutro Biopharma
STRO
$85.6M
| $2.11M | 0.56% |
+210,000
| New | +$2.11M |
|
|
TECX
58
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
| $2.09M | 0.55% |
160,624
-29,969
| -16% | -$390K |
|
|
EIDX
59
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $2.08M | 0.55% |
41,091
+6
| +0% | +$303 |
|
60
Aurinia Pharmaceuticals
AUPH
$1.58B
| $1.92M | 0.51% |
130,312
+24
| +0% | +$353 |
|
61
Novavax
NVAX
$1.2B
| $1.9M | 0.5% |
17,500
-22,500
| -56% | -$2.44M |
|
62
Nephros
NEPH
$44M
| $1.75M | 0.46% |
241,411
-9,955
| -4% | -$72K |
|
63
MeiraGTx Holdings
MGTX
$590M
| $1.73M | 0.46% |
130,763
-4,237
| -3% | -$56.1K |
|
|
MSON
64
DELISTED
Misonix Inc
MSON
| $1.59M | 0.42% |
135,596
+5,599
| +4% | +$65.7K |
|
65
Castle Biosciences
CSTL
$673M
| $1.54M | 0.41% |
30,003
+5,003
| +20% | +$257K |
|
66
Axogen
AXGN
$718M
| $1.45M | 0.39% |
+125,000
| New | +$1.45M |
|
|
SURF
67
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $1.38M | 0.37% |
200,019
+75,019
| +60% | +$518K |
|
|
INOV
68
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $1.32M | 0.35% |
+50,000
| New | +$1.32M |
|
|
PROF
69
Profound Medical
PROF
$131M
| $1.24M | 0.33% |
+70,000
| New | +$1.24M |
|
70
QuidelOrtho
QDEL
$1.87B
| $1.1M | 0.29% |
5,001
-999
| -17% | -$219K |
|
71
RAPT Therapeutics
RAPT
$187M
| $966K | 0.26% |
30,010
-9,990
| -25% | -$322K |
|
72
Astria Therapeutics
ATXS
$394M
| $901K | 0.24% |
145,501
-9,972
| -6% | -$61.8K |
|
73
Gyre Therapeutics
GYRE
$734M
| $896K | 0.24% |
208,478
-6,759
| -3% | -$29K |
|
74
Dynavax Technologies
DVAX
$1.19B
| $864K | 0.23% |
+200,000
| New | +$864K |
|
75
MannKind Corp
MNKD
$1.69B
| $660K | 0.17% |
351,230
-199,887
| -36% | -$376K |
|